Reveal HealthTech raises $7.2M in Series A funding led by Leo Capital | AIM posted on the topic | LinkedIn

Reveal HealthTech, a two-year-old healthcare AI company founded in 2023 and incubated by W Health Ventures and 2070 Health, has raised $7.2 million in Series A funding led by Leo Capital, with participation from Sanos Capital. The funding marks a major milestone as the company positions itself as a “healthcare AI specialist,” working with US healthcare and life sciences organisations to design safe and clinically relevant AI systems.

“With Reveal, that vision is becoming reality. By acting on data in real-time, we’re not only improving patient experiences but also easing the burden on clinicians,” said Dr Sumir Sahgal MD, founder and chief medical officer of Essen Health Care, highlighting the company’s transformative role in patient care.

Reveal’s portfolio includes BioCanvas, which supports multimodal AI use cases like clinical trial recruitment, and Prism AI, a platform that builds intelligent agents to automate healthcare workflows. In one recent project with a $40 billion U.S. medical device company, Reveal integrated patient data to improve adherence and built a reusable blueprint for future deployments.

“Our mission is simple but bold—we want to make AI the most trusted and accountable partner in healthcare,” said Sanchit Mullick, founder of Reveal HealthTech. Echoing this confidence, Rajul Garg, partner at Leo Capital, noted: “Their superpower lies in crafting solutions that demonstrate time-bound, business goodness to clients. We’re very excited to support the team in its next phase of growth.”